Mary Beckerle - Johnson Johnson Director
JNJ Stock | EUR 140.06 0.94 0.67% |
Director
Dr. Mary C. Beckerle, Ph.D., is an Independent Director of the Company. She has served as CEO of Huntsman Cancer Institute at the University of Utah since 2006. She is the associate vice president for cancer affairs and a distinguished professor of biology and oncological sciences at the University of Utah. Dr. Beckerle joined the faculty of the University of Utah in 1986 and currently holds the Jon M. Huntsman Presidential Endowed Chair. Dr. Beckerle has served on the National Institute of Health Advisory Committee to the Director, on the Board of Directors of the American Association for Cancer Research, as president of the American Society for Cell Biology, and as the Chair of the American Cancer Society Council for Extramural Grants. She currently serves on a number of scientific advisory boards, including the Medical Advisory Board of the Howard Hughes Medical Institute, and the Scientific Advisory Boards of the National Center for Biological Sciences at the Tata Institute of Fundamental Research in India, the Mechanobiology Institute in Singapore, and the Dana FarberHarvard Cancer Center. Dr. Beckerle held a Guggenheim Fellowship at the Curie Institute in Paris, received the Utah Governors Medal for Science and Technology in 2001, the Sword of Hope Award from the American Cancer Society in 2004 and is an elected Fellow of the American Academy of Arts and Sciences and the American Philosophical Society. Dr. Beckerle was also named a National Association of Corporationrationrate Directors Governance Fellow in 2012. since 2015.
Age | 63 |
Tenure | 9 years |
Phone | 732 524 0400 |
Web | https://www.jnj.com |
Johnson Johnson Management Efficiency
The company has return on total asset (ROA) of 0.0871 % which means that it generated a profit of $0.0871 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2379 %, meaning that it generated $0.2379 on every $100 dollars invested by stockholders. Johnson Johnson's management efficiency ratios could be used to measure how well Johnson Johnson manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | DIRECTOR Age | ||
York Dyckerhoff | Air New Zealand | 51 | |
Michael Glenn | Pentair plc | 62 | |
Oliviero Brega | Air New Zealand | 72 | |
Theodore Harris | Pentair plc | 53 | |
Michele Buzzi | Air New Zealand | 56 | |
Michael Speetzen | Pentair plc | 48 | |
Bruns Grayson | Ribbon Communications | 71 | |
Paolo Burlando | Air New Zealand | 56 | |
Linda Gilli | Air New Zealand | 66 | |
Antonella Musy | Air New Zealand | 51 | |
Maurizio Sella | Air New Zealand | 77 | |
Jacques Esculier | Pentair plc | 58 | |
Marco Weigmann | Air New Zealand | 75 | |
Pietro Buzzi | Air New Zealand | 58 | |
Ronald Merriman | Pentair plc | 73 | |
Gianfelice Rocca | Air New Zealand | 71 | |
Billie Williamson | Pentair plc | 65 | |
Luca Fabbro | Air New Zealand | 52 | |
David Jones | Pentair plc | 60 | |
Elsa Fornero | Air New Zealand | 71 | |
Glynis Bryan | Pentair plc | 59 |
Management Performance
Return On Equity | 0.24 | |||
Return On Asset | 0.0871 |
Johnson Johnson Leadership Team
Elected by the shareholders, the Johnson Johnson's board of directors comprises two types of representatives: Johnson Johnson inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Johnson. The board's role is to monitor Johnson Johnson's management team and ensure that shareholders' interests are well served. Johnson Johnson's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Johnson Johnson's outside directors are responsible for providing unbiased perspectives on the board's policies.
Dirk Brinckman, Chief Officer | ||
Jennifer Doudna, Independent Director | ||
Alex Gorsky, Chairman of the Board, CEO | ||
William Perez, Independent Director | ||
Michael Sneed, Executive Vice President - Global Corporate Affairs and Chief Communication Officer | ||
Marillyn Hewson, Independent Director | ||
Jorge Mesquita, Executive Vice President Worldwide Chairman - Consumer | ||
Mary Coleman, Independent Director | ||
Michael Ullmann, Vice President General Counsel | ||
Joaquin Duato, Executive Vice President Worldwide Chairman - Pharmaceuticals | ||
Joseph CPA, Ex CFO | ||
Kathy Wengel, Executive Vice President Chief Global Supply Chain Officer | ||
Jennifer Taubert, Executive Vice President - Worldwide Chairman, Pharmaceuticals | ||
Mary Beckerle, Director | ||
Sandra Peterson, Group Worldwide Chairman | ||
Scott Davis, Director | ||
Louise Mehrotra, Vice President Investor Relations | ||
Robert Decker, Controller Officer | ||
Ashley McEvoy, Executive Vice President - Worldwide Chairman, Medical Devices | ||
Ronald Williams, Independent Director | ||
Kathryn Wengel, Executive Vice President Chief Global Supply Chain Officer | ||
James Swanson, Ex Officer | ||
Anne Mulcahy, Lead Independent Director | ||
Joseph Wolk, Vice President - Investor Relations | ||
Thibaut Mongon, Executive Vice President Worldwide Chairman, Consumer | ||
Jessica Moore, VP Relations | ||
Ian Davis, Independent Director | ||
Paulus Stoffels, Chief Scientific Officer, Worldwide Chairman - Pharmaceuticals Group | ||
Mark McClellan, Independent Director | ||
Charles Prince, Independent Director | ||
Eugene Washington, Independent Director | ||
Elizabeth Forminard, Exec Counsel | ||
Dominic Caruso, CFO, Vice President - Finance | ||
Peter Fasolo, Vice President - Global Human Resources | ||
Susan Lindquist, Independent Director |
Johnson Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Johnson Johnson a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.24 | |||
Return On Asset | 0.0871 | |||
Profit Margin | 0.19 % | |||
Operating Margin | 0.27 % | |||
Current Valuation | 443.95 B | |||
Shares Outstanding | 2.6 B | |||
Shares Owned By Insiders | 0.09 % | |||
Shares Owned By Institutions | 71.60 % | |||
Price To Earning | 29.33 X | |||
Price To Book | 6.28 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Johnson Johnson in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Johnson Johnson's short interest history, or implied volatility extrapolated from Johnson Johnson options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Johnson Johnson. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Johnson Stock please use our How to Invest in Johnson Johnson guide.You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Complementary Tools for Johnson Stock analysis
When running Johnson Johnson's price analysis, check to measure Johnson Johnson's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Johnson Johnson is operating at the current time. Most of Johnson Johnson's value examination focuses on studying past and present price action to predict the probability of Johnson Johnson's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Johnson Johnson's price. Additionally, you may evaluate how the addition of Johnson Johnson to your portfolios can decrease your overall portfolio volatility.
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |